Gross Margin and Profit Increase
Gross margin for Q2 increased to 18.5% from 15%, with gross profit rising to $7.7 million from $6.3 million in the same quarter of fiscal 2024.
Nicotine Business Performance
Nicotine business accounted for $31 million of overall revenue, marking strong performance and expansion into new international markets, particularly in Africa.
Successful Product Launch in Africa
Launch of BrkFst nicotine product in South Africa and Nigeria, with a presence in over 500 retail locations, expected to expand to over 2,000 stores in six months.
Regulatory Approvals in Malaysia
Obtained nicotine import and export licenses from the Malaysian government, nearing completion of manufacturers license, enhancing operational capabilities.
Stock Repurchase Program
Board authorized a $10 million stock repurchase program through January 2027, reflecting confidence in Ispire's long-term vision.
Positive Cash Flow from Operations
Net cash provided by operating activities was $0.4 million, a significant improvement from $20.2 million used in the same period last year.
Component PMTA Strategy
Successful pre-PMTA meeting with FDA for age-gating technology, with potential to enter a $7 billion market opportunity in the U.S.